Rector & Visitors of the University of Virginia

Rector & Visitors of the University of Virginia was paid $500.55M by Medicaid between Jan 2018 and Dec 2024, across 1033 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 14% of everything it billed.

33Billing provider infoRECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA
CHARLOTTESVILLE, VA 22908

33aNPI1780630608assigned 05/25/2006

33bProvider typeClinical Medical Laboratory

28Total paid$500.55M

24GClaims7,181,828

24DCodes billed1033

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#1 of 78

Median peer was paid$37K

This provider vs. median13,585×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	954,321	$34.00M
2019	1,079,230	$44.37M
2020	884,601	$50.23M
2021	1,062,977	$63.35M
2022	1,136,287	$90.32M
2023	1,148,164	$124.07M
2024incomplete	916,248	$94.20M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	14%	351,075	291,661	$71.13M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	10%	246,914	206,988	$50.68M
90935	Hemodialysis procedure with single evaluation by a physician	8.6%	139,146	10,813	$43.00M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	4.8%	113,575	100,224	$23.79M
J9271	Injection, pembrolizumab, 1 mg	2.4%	2,057	1,384	$12.18M
90945		2.3%	30,499	954	$11.34M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.0%	40,206	32,897	$9.97M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.0%	41,525	34,990	$9.88M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	1.9%	7,127	2,129	$9.59M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.9%	38,251	32,949	$9.39M
96361	Intravenous infusion, hydration; each additional hour	1.6%	17,132	12,692	$7.81M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.5%	37,717	32,287	$7.62M

1021 more codes

93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.5%	14,886	$7.33M
J2350	Injection, ocrelizumab, 1 mg	1.0%	286	$5.19M
G0378	Hospital observation service, per hour	1.0%	33,795	$5.01M
99204	Doctor's office visit, new patient (more involved)	<1%	23,081	$4.70M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	24,071	$4.49M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,355	$4.41M
96415		<1%	8,406	$4.32M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	24,029	$3.91M
99215	Doctor's office visit, returning patient (complex)	<1%	21,124	$3.88M
99203	Doctor's office visit, new patient (routine)	<1%	17,401	$3.49M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	1,849	$3.26M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	10,233	$3.23M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,844	$3.03M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,165	$2.98M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	173,265	$2.74M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	3,156	$2.68M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	1,811	$2.67M
59025	Fetal non-stress test	<1%	8,544	$2.55M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,010	$2.52M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	10,974	$2.51M
80053	Comprehensive metabolic panel	<1%	218,903	$2.51M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	11,806	$2.49M
93308		<1%	4,903	$2.44M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	31,895	$2.41M
J9299	Injection, nivolumab, 1 mg	<1%	700	$2.37M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,506	$2.36M
20610		<1%	9,398	$2.34M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	7,517	$2.18M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	5,141	$2.15M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	9,085	$2.12M
70450	Computed tomography, head or brain; without contrast material	<1%	8,529	$2.02M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	675	$1.99M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	18,415	$1.97M
43235		<1%	2,289	$1.92M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,168	$1.91M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	622	$1.79M
76770		<1%	8,233	$1.76M
97163		<1%	10,264	$1.75M
95812		<1%	2,374	$1.67M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	30,378	$1.63M
96112		<1%	1,916	$1.62M
77386		<1%	2,767	$1.61M
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	65,683	$1.59M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	1,116	$1.56M
92521		<1%	7,813	$1.54M
J3490	Unclassified drugs	<1%	388,874	$1.47M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,865	$1.39M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,291	$1.39M
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,845	$1.36M
Q5105	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units	<1%	65,075	$1.36M
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	285	$1.34M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	9,565	$1.22M
20553		<1%	4,195	$1.21M
67028	Intravitreal injection of a pharmacologic agent	<1%	4,296	$1.18M
J9312	Injection, rituximab, 10 mg	<1%	487	$1.18M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,127	$1.16M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,008	$1.15M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	11,301	$1.15M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,899	$1.09M
J0178	Injection, aflibercept, 1 mg	<1%	947	$1.08M
97167		<1%	7,722	$1.07M
90837	Psychotherapy session, about an hour	<1%	6,125	$1.03M
93320		<1%	5,302	$1.00M
31575		<1%	4,266	$970K
C9257	Injection, bevacizumab, 0.25 mg	<1%	2,130	$963K
92588		<1%	4,903	$933K
90791	Psychiatric diagnostic evaluation	<1%	3,305	$869K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	12,555	$855K
52000		<1%	691	$850K
90999	Dialysis (unlisted procedure)	<1%	29,052	$812K
50435		<1%	722	$810K
90792	Psychiatric diagnostic evaluation with medical services	<1%	2,923	$804K
96040		<1%	6,002	$796K
93304		<1%	1,814	$769K
11102		<1%	1,567	$758K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,119	$757K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	8,195	$756K
36430		<1%	3,281	$754K
64615		<1%	1,468	$728K
80048	Basic metabolic panel (calcium, ionized)	<1%	94,665	$728K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	7,255	$722K
93325		<1%	11,147	$715K
J2357	Injection, omalizumab, 5 mg	<1%	1,622	$699K
Q3014	Telehealth originating site facility fee	<1%	37,724	$671K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,781	$667K
J0604	Cinacalcet, oral, 1 mg, (for esrd on dialysis)	<1%	2,609	$665K
J0897	Injection, denosumab, 1 mg	<1%	1,350	$651K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	10,596	$646K
J0485	Injection, belatacept, 1 mg	<1%	1,745	$645K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	23,455	$645K
77412		<1%	1,213	$637K
96367		<1%	5,806	$632K
95885		<1%	2,651	$631K
J0606	Injection, etelcalcetide, 0.1 mg	<1%	22,075	$619K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	8,410	$614K
96116		<1%	1,008	$613K
95886		<1%	3,063	$607K
31231		<1%	2,331	$607K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	8,725	$598K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,532	$587K
31579		<1%	771	$580K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	258	$562K
64721		<1%	400	$561K
70496		<1%	1,496	$546K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,587	$544K
76801		<1%	4,429	$538K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	83,636	$536K
90686		<1%	35,506	$516K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,790	$509K
20611		<1%	869	$505K
J9035	Injection, bevacizumab, 10 mg	<1%	261	$499K
76642		<1%	3,157	$494K
76819	Fetal biophysical profile; without non-stress testing	<1%	5,462	$490K
95782		<1%	454	$489K
90834	Psychotherapy session, about 45 minutes	<1%	2,974	$477K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	475	$473K
93017		<1%	3,151	$467K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	3,922	$460K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	28,910	$459K
17110		<1%	2,014	$457K
93970		<1%	2,778	$446K
74174		<1%	1,257	$439K
96132		<1%	1,559	$432K
93971		<1%	3,339	$428K
41899	Unlisted procedure, dentoalveolar structures	<1%	208	$421K
93321		<1%	5,571	$420K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	870	$413K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	408	$405K
81229		<1%	1,653	$403K
54161		<1%	132	$399K
87536		<1%	5,748	$397K
90651		<1%	6,996	$396K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,780	$394K
94618		<1%	3,676	$391K
36415	Collection of venous blood by venipuncture	<1%	287,506	$390K
58100		<1%	866	$386K
58300		<1%	1,579	$385K
92557		<1%	3,837	$376K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	30,693	$374K
97803		<1%	1,547	$374K
77336		<1%	3,659	$372K
43762		<1%	1,273	$363K
84443	Thyroid stimulating hormone (TSH)	<1%	68,969	$359K
20550		<1%	1,312	$356K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	25,367	$355K
77334		<1%	2,003	$351K
93922		<1%	3,477	$350K
74183		<1%	945	$349K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	160,953	$344K
49083		<1%	496	$343K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,282	$334K
90832	Psychotherapy session, about 30 minutes	<1%	2,335	$334K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	61,171	$332K
11900		<1%	1,165	$329K
76775		<1%	1,945	$321K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,627	$321K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	430	$315K
83036	Hemoglobin; glycosylated (A1C)	<1%	72,040	$309K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	8,056	$304K
92579		<1%	2,616	$303K
94010		<1%	13,309	$301K
85027		<1%	165,085	$299K
80061	Lipid panel	<1%	48,593	$299K
64642		<1%	1,083	$293K
58661		<1%	49	$292K
95811		<1%	426	$292K
J2323	Injection, natalizumab, 1 mg	<1%	210	$285K
11981		<1%	699	$283K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	12,184	$282K
20605		<1%	1,183	$282K
76830	Ultrasound, transvaginal	<1%	2,255	$282K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,736	$277K
62323		<1%	361	$272K
71250		<1%	2,438	$271K
71046	Radiologic examination, chest; 2 views	<1%	19,751	$269K
11104		<1%	431	$269K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	124	$268K
83970		<1%	14,178	$263K
64493		<1%	294	$263K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,088	$262K
20552		<1%	948	$260K
76937		<1%	3,960	$254K
83880		<1%	15,440	$254K
29075		<1%	859	$253K
20680		<1%	184	$252K
90677		<1%	3,414	$251K
75574		<1%	553	$250K
99205	Prolong outpt/office vis	<1%	1,458	$243K
93296		<1%	6,853	$242K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	983	$235K
70491		<1%	970	$235K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	22,725	$234K
87086	Culture, bacterial; quantitative colony count, urine	<1%	38,053	$233K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	4,601	$231K
86923		<1%	7,421	$228K
90715		<1%	10,423	$227K
J0475	Injection, baclofen, 10 mg	<1%	905	$226K
92551		<1%	2,349	$223K
93880		<1%	1,834	$218K
76820		<1%	3,418	$216K
51728		<1%	623	$216K
88142		<1%	12,536	$216K
51600		<1%	926	$214K
10005		<1%	440	$213K
95816		<1%	802	$212K
95700		<1%	722	$210K
51741		<1%	1,399	$208K
86780		<1%	19,400	$205K
90670		<1%	11,790	$204K
52356		<1%	30	$204K
76536		<1%	1,253	$204K
64643		<1%	521	$203K
43264		<1%	144	$197K
77300		<1%	1,395	$192K
92567		<1%	8,946	$188K
42830		<1%	64	$184K
96416		<1%	735	$184K
97802		<1%	1,158	$183K
A0425	Ground mileage, per statute mile	<1%	1,897	$183K
92083		<1%	4,226	$182K
51784		<1%	944	$182K
87081		<1%	20,546	$180K
76942		<1%	2,861	$180K
80076		<1%	15,822	$177K
92134		<1%	8,740	$171K
77470		<1%	222	$170K
88185		<1%	2,562	$170K
J1756	Injection, iron sucrose, 1 mg	<1%	5,404	$168K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	23,440	$167K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	267	$166K
97162		<1%	1,648	$166K
86803		<1%	21,052	$165K
J2505	Injection, pegfilgrastim, 6 mg	<1%	72	$164K
20600		<1%	612	$164K
76512		<1%	1,027	$160K
38222		<1%	139	$158K
97166		<1%	1,848	$156K
77295		<1%	161	$152K
93925		<1%	1,096	$150K
87507		<1%	1,875	$150K
75561		<1%	252	$150K
C1776	Joint device (implantable)	<1%	488	$149K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,307	$148K
86481		<1%	5,960	$145K
87799		<1%	6,491	$142K
87510		<1%	8,650	$140K
74018		<1%	7,968	$138K
94729		<1%	7,294	$138K
90682		<1%	8,030	$137K
86832		<1%	4,556	$136K
87497		<1%	7,451	$136K
95806		<1%	484	$134K
76885		<1%	640	$133K
87522	Neg quan hep c or qual rna	<1%	3,945	$129K
0225U		<1%	757	$128K
96138		<1%	1,597	$128K
92585		<1%	276	$127K
11982		<1%	343	$125K
17000		<1%	1,040	$124K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	772	$123K
74455		<1%	678	$121K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	493	$120K
77001		<1%	936	$117K
92524		<1%	422	$116K
93975		<1%	1,120	$116K
72082		<1%	5,101	$115K
58301		<1%	460	$115K
80197		<1%	13,410	$113K
82728		<1%	30,059	$111K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	265	$111K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,927	$109K
76882		<1%	812	$109K
J9310	Injection, rituximab, 100 mg	<1%	68	$108K
91320		<1%	1,872	$108K
92060		<1%	1,919	$107K
84439		<1%	27,075	$107K
92020		<1%	661	$106K
95910		<1%	1,589	$105K
83655		<1%	1,709	$105K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	62,216	$103K
84403		<1%	5,997	$103K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	1,114	$102K
0001A		<1%	2,727	$101K
74230		<1%	896	$101K
83735		<1%	59,200	$99K
90648		<1%	13,073	$98K
0002A		<1%	2,428	$97K
92025		<1%	449	$97K
72110		<1%	3,394	$96K
95117		<1%	2,301	$96K
19083		<1%	45	$95K
76870		<1%	581	$91K
71045	Radiologic examination, chest; single view	<1%	21,168	$90K
72141		<1%	393	$89K
77062		<1%	1,101	$88K
36902		<1%	75	$87K
72170		<1%	5,047	$87K
20526		<1%	296	$87K
85610		<1%	49,604	$86K
91200		<1%	597	$86K
76825		<1%	795	$85K
73130		<1%	3,733	$85K
87660		<1%	8,650	$84K
99173		<1%	2,739	$83K
94726		<1%	3,580	$82K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	466	$82K
J2997	Injection, alteplase recombinant, 1 mg	<1%	1,447	$82K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	7,261	$81K
70498		<1%	1,327	$81K
93225		<1%	1,632	$81K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	17,152	$78K
90734		<1%	4,938	$77K
95951		<1%	217	$77K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,601	$77K
88307		<1%	3,607	$76K
87430		<1%	7,145	$76K
86833		<1%	4,538	$75K
C1769	Guide wire	<1%	14,291	$75K
88341		<1%	3,206	$75K
82607		<1%	13,674	$74K
77290		<1%	206	$74K
11719		<1%	2,812	$74K
92133		<1%	4,164	$73K
92552		<1%	951	$72K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	40,697	$72K
29405		<1%	226	$70K
90723		<1%	9,833	$70K
77061		<1%	947	$70K
74240		<1%	443	$69K
43760		<1%	255	$68K
90480		<1%	2,951	$68K
82962		<1%	62,033	$66K
82784		<1%	9,916	$66K
73100		<1%	1,841	$65K
92250		<1%	4,180	$65K
81003		<1%	48,899	$65K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	475	$64K
C1758	Catheter, ureteral	<1%	2,310	$64K
82670		<1%	2,526	$63K
97165		<1%	540	$63K
93505		<1%	94	$61K
94060		<1%	1,514	$61K
29827		<1%	15	$60K
93976		<1%	329	$60K
J2501	Injection, paricalcitol, 1 mcg	<1%	81,547	$60K
81025		<1%	28,992	$59K
17250		<1%	213	$59K
72100		<1%	3,585	$59K
36591		<1%	11,165	$58K
10060		<1%	330	$58K
85018		<1%	26,272	$58K
31624		<1%	54	$58K
64635		<1%	62	$58K
51798		<1%	2,944	$57K
90633		<1%	7,862	$57K
62370		<1%	546	$57K
87480		<1%	8,644	$57K
86140		<1%	26,449	$56K
77066	Tomosynthesis, mammo	<1%	1,806	$55K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,730	$55K
95908		<1%	826	$55K
84100		<1%	51,201	$55K
83516		<1%	5,679	$54K
31615		<1%	29	$54K
72040		<1%	2,511	$54K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	199	$54K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	854	$54K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	30,604	$53K
84466		<1%	29,566	$53K
86360		<1%	5,723	$53K
87040		<1%	5,072	$53K
77065	Tomosynthesis, mammo	<1%	1,450	$53K
73110		<1%	2,261	$52K
90716		<1%	3,739	$51K
94660		<1%	135	$50K
87147		<1%	11,548	$50K
73590		<1%	3,006	$50K
86235		<1%	1,677	$50K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	903	$49K
86003		<1%	4,465	$49K
90381		<1%	152	$49K
87070		<1%	9,976	$48K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,192	$47K
84146		<1%	3,075	$46K
93923		<1%	648	$46K
73140		<1%	1,422	$45K
27096		<1%	70	$45K
95909		<1%	742	$44K
84702		<1%	5,131	$44K
73630		<1%	3,305	$44K
88112		<1%	2,574	$44K
72050		<1%	1,961	$44K
90681		<1%	6,275	$44K
90472	Immunization administration, each additional vaccine (list separately)	<1%	19,373	$43K
84484		<1%	28,669	$43K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	43	$43K
73090		<1%	2,284	$43K
64450		<1%	147	$42K
92523		<1%	222	$41K
82570		<1%	29,304	$40K
86359		<1%	5,724	$40K
83001		<1%	3,199	$40K
77072		<1%	1,790	$40K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	7,507	$40K
90656		<1%	2,429	$39K
81001		<1%	45,423	$39K
81243		<1%	930	$39K
58558		<1%	16	$39K
92235		<1%	125	$38K
72197		<1%	74	$38K
77080		<1%	406	$38K
73564		<1%	3,300	$37K
99453		<1%	474	$37K
83540		<1%	29,813	$37K
90378		<1%	204	$36K
73610		<1%	3,066	$36K
99201		<1%	277	$36K
88184		<1%	2,579	$36K
90710		<1%	2,745	$36K
90380		<1%	86	$35K
80348		<1%	3,834	$35K
85007		<1%	19,085	$35K
86850		<1%	24,506	$35K
92555		<1%	876	$35K
76000		<1%	3,881	$35K
82533		<1%	2,711	$34K
88342		<1%	6,105	$34K
J0690	Injection, cefazolin sodium, 500 mg	<1%	26,412	$34K
95819		<1%	105	$33K
87340		<1%	17,889	$33K
86317		<1%	2,924	$33K
96409		<1%	635	$32K
92610		<1%	211	$32K
0399T		<1%	204	$32K
36592		<1%	2,466	$32K
87517		<1%	1,234	$31K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	1,130	$31K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	22,895	$30K
92504		<1%	258	$30K
83020		<1%	3,673	$30K
86665		<1%	2,456	$29K
J8540	Dexamethasone, oral, 0.25 mg	<1%	8,164	$28K
36589		<1%	60	$28K
17311		<1%	31	$28K
82043		<1%	18,838	$28K
82105		<1%	4,330	$28K
97161		<1%	302	$28K
70486		<1%	276	$27K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	597	$27K
47000		<1%	30	$27K
90707		<1%	3,522	$27K
87077		<1%	9,978	$27K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	676	$27K
77002		<1%	538	$27K
73030		<1%	2,751	$27K
90747		<1%	840	$26K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	15,050	$26K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,455	$26K
85379		<1%	4,232	$26K
90732		<1%	2,014	$26K
64612		<1%	194	$26K
90700		<1%	3,598	$25K
12001		<1%	109	$25K
J7050	Infusion, normal saline solution, 250 cc	<1%	28,177	$25K
86304		<1%	1,703	$25K
77003		<1%	150	$25K
38525		<1%	14	$25K
82024		<1%	932	$25K
76827		<1%	439	$24K
A4657	Syringe, with or without needle, each	<1%	62,249	$24K
86480		<1%	724	$24K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	56	$24K
83605		<1%	15,085	$24K
29125		<1%	139	$24K
64644		<1%	135	$24K
0072A		<1%	499	$24K
86900		<1%	25,304	$24K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,389	$23K
80320		<1%	6,071	$23K
86706		<1%	9,984	$23K
82785		<1%	5,251	$23K
77280		<1%	81	$23K
90746		<1%	1,227	$23K
57454		<1%	43	$23K
95714		<1%	38	$23K
99152		<1%	9,313	$23K
85652		<1%	25,436	$23K
97597		<1%	104	$22K
83883		<1%	3,148	$21K
87186		<1%	12,443	$21K
86704		<1%	7,755	$21K
0071A		<1%	615	$21K
87116		<1%	1,760	$21K
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	1,943	$21K
0352U		<1%	2,913	$21K
90461		<1%	8,677	$21K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,357	$21K
88313		<1%	2,712	$20K
96376		<1%	8,860	$20K
76978		<1%	123	$20K
96136		<1%	341	$20K
86787		<1%	5,952	$20K
86038		<1%	4,675	$20K
90673		<1%	1,141	$19K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	32	$19K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	29	$19K
J7030	Infusion, normal saline solution , 1000 cc	<1%	29,382	$19K
84153		<1%	3,030	$19K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	45	$19K
73502		<1%	1,775	$19K
86901		<1%	25,124	$18K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	945	$18K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	48	$18K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	2,292	$18K
0124A		<1%	1,491	$18K
96411		<1%	1,667	$18K
0115U		<1%	699	$18K
73070		<1%	1,100	$18K
64494		<1%	225	$18K
80329		<1%	1,647	$18K
96139		<1%	1,523	$18K
90696		<1%	2,315	$17K
11100		<1%	226	$17K
93926		<1%	173	$17K
93298		<1%	318	$17K
73080		<1%	1,060	$17K
86762		<1%	5,458	$17K
86258		<1%	3,144	$17K
83002		<1%	1,939	$16K
96381		<1%	256	$16K
91318		<1%	694	$16K
90662		<1%	1,966	$16K
G0008	Administration of influenza virus vaccine	<1%	7,636	$16K
64405		<1%	54	$16K
86376		<1%	932	$16K
91010		<1%	26	$16K
90636		<1%	144	$16K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	148	$16K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	12,930	$15K
86160		<1%	2,984	$15K
S9342	Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem	<1%	82	$15K
80164		<1%	1,894	$15K
84481		<1%	2,413	$15K
80324		<1%	1,172	$15K
84270		<1%	3,016	$14K
0082A		<1%	275	$14K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,896	$14K
74221		<1%	142	$14K
72158		<1%	59	$14K
93280		<1%	1,329	$14K
78264		<1%	27	$14K
J1750	Injection, iron dextran, 50 mg	<1%	126	$14K
88323		<1%	370	$14K
83690		<1%	21,053	$14K
82746		<1%	6,155	$14K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	2,196	$14K
49180		<1%	44	$13K
78816		<1%	17	$13K
12011		<1%	63	$13K
71271		<1%	102	$13K
86664		<1%	1,813	$13K
70250		<1%	553	$13K
80179		<1%	2,461	$13K
72080		<1%	642	$13K
86255		<1%	1,088	$13K
86301		<1%	816	$13K
93282		<1%	776	$13K
78306		<1%	39	$13K
91319		<1%	378	$13K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	11,565	$13K
83050		<1%	10,413	$13K
73560		<1%	1,379	$13K
82803		<1%	11,560	$12K
99153	Mod sedat endo service >5yrs	<1%	8,057	$12K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	12	$12K
87529		<1%	462	$12K
62305		<1%	28	$12K
96375	Therapeutic injection; each additional sequential IV push	<1%	26,626	$12K
96133		<1%	1,367	$11K
92604		<1%	91	$11K
82565		<1%	12,803	$11K
80349		<1%	3,463	$11K
82274		<1%	848	$11K
88360		<1%	613	$11K
84132		<1%	13,468	$11K
73552		<1%	872	$11K
29515		<1%	32	$11K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	267	$11K
29826		<1%	13	$11K
88304		<1%	2,817	$10K
95911		<1%	133	$10K
86695		<1%	1,086	$10K
82951		<1%	552	$10K
84703		<1%	3,475	$10K
C1729	Catheter, drainage	<1%	2,447	$10K
80050	General health panel	<1%	570	$10K
72132		<1%	155	$10K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	14,538	$10K
82550		<1%	7,568	$10K
96402		<1%	764	$10K
87102		<1%	2,809	$10K
93297		<1%	333	$10K
92582		<1%	110	$10K
62270		<1%	13	$9K
64447		<1%	16	$9K
C1889	Implantable/insertable device, not otherwise classified	<1%	1,250	$9K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	31,303	$9K
86663		<1%	1,001	$9K
84156		<1%	11,916	$9K
86364		<1%	3,146	$9K
88720		<1%	1,247	$9K
86308		<1%	1,929	$9K
88312		<1%	1,356	$9K
92002		<1%	93	$9K
83615		<1%	10,160	$9K
29065		<1%	34	$9K
72081		<1%	215	$8K
80178		<1%	869	$8K
87210		<1%	1,802	$8K
0081A		<1%	385	$8K
95874		<1%	1,197	$8K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,422	$8K
82248		<1%	2,913	$8K
90713		<1%	1,082	$8K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	24,232	$8K
J2704	Injection, propofol, 10 mg	<1%	60,966	$8K
85730		<1%	19,455	$8K
88365		<1%	651	$8K
75572		<1%	27	$8K
84550		<1%	8,788	$8K
80346		<1%	604	$8K
87902		<1%	145	$8K
C1726	Catheter, balloon dilatation, non-vascular	<1%	867	$8K
12002		<1%	28	$8K
82330		<1%	11,520	$8K
82247		<1%	1,128	$8K
96368		<1%	1,508	$8K
Q0139	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)	<1%	76	$8K
93270		<1%	227	$8K
67228		<1%	18	$8K
88350		<1%	195	$8K
96450		<1%	15	$8K
83921		<1%	2,239	$8K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	53,930	$7K
86300		<1%	1,155	$7K
96401		<1%	374	$7K
96118		<1%	230	$7K
68761		<1%	18	$7K
90870		<1%	61	$7K
95711		<1%	51	$7K
A4648	Tissue marker, implantable, any type, each	<1%	770	$7K
86644		<1%	762	$7K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	40,038	$7K
93283		<1%	492	$7K
64400		<1%	27	$7K
93284		<1%	526	$7K
87205		<1%	6,582	$7K
80361		<1%	561	$6K
86431		<1%	2,421	$6K
88271		<1%	179	$6K
99454		<1%	92	$6K
85045		<1%	6,059	$6K
88173		<1%	1,826	$6K
51702		<1%	306	$6K
88237		<1%	177	$6K
87631		<1%	150	$6K
92556		<1%	417	$6K
82977		<1%	3,831	$6K
92136		<1%	242	$6K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	17	$6K
76506		<1%	32	$6K
86696		<1%	1,085	$6K
89051		<1%	3,564	$6K
96417		<1%	4,353	$6K
87486		<1%	219	$5K
96121		<1%	197	$5K
88262		<1%	156	$5K
97535	Self-care/home management training, each 15 minutes	<1%	371	$5K
74178		<1%	15	$5K
J1815	Injection, insulin, per 5 units	<1%	11,625	$5K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	5,047	$5K
80202		<1%	597	$5K
84165		<1%	3,576	$5K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,032	$5K
29085		<1%	16	$5K
82627		<1%	452	$5K
76813		<1%	26	$5K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	36,930	$5K
86945		<1%	3,303	$5K
86580		<1%	780	$5K
93299		<1%	133	$5K
95115		<1%	187	$5K
74019		<1%	624	$5K
90474		<1%	3,838	$5K
85097		<1%	206	$5K
72126		<1%	71	$5K
0004A		<1%	156	$5K
S8101	Holding chamber or spacer for use with an inhaler or nebulizer; with mask	<1%	553	$5K
81455		<1%	27	$5K
76604		<1%	29	$5K
73060		<1%	608	$4K
0154A		<1%	167	$4K
82150		<1%	3,306	$4K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	4,670	$4K
90836		<1%	16	$4K
0054A		<1%	389	$4K
J1644	Injection, heparin sodium, per 1000 units	<1%	37,581	$4K
J9045	Injection, carboplatin, 50 mg	<1%	1,367	$4K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	30	$4K
64636		<1%	48	$4K
92285		<1%	172	$4K
87581		<1%	232	$4K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,228	$4K
J9070	Cyclophosphamide, 100 mg	<1%	18	$4K
83010		<1%	1,294	$4K
72146		<1%	57	$4K
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	86	$4K
93243		<1%	87	$4K
84520		<1%	8,466	$4K
51797		<1%	769	$4K
90620		<1%	90	$4K
74220		<1%	137	$4K
91038		<1%	25	$4K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	5,710	$4K
86225		<1%	2,598	$4K
10022		<1%	33	$4K
51701		<1%	200	$4K
70360		<1%	276	$4K
82375		<1%	10,214	$4K
0173A		<1%	102	$4K
82310		<1%	2,264	$4K
82810		<1%	2,001	$4K
11200		<1%	27	$3K
74328		<1%	13	$3K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,172	$3K
80359		<1%	1,171	$3K
82950		<1%	3,812	$3K
80175		<1%	462	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,624	$3K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	399	$3K
90678		<1%	88	$3K
L3807	Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	155	$3K
88300		<1%	969	$3K
J1170	Injection, hydromorphone, up to 4 mg	<1%	21,211	$3K
82952		<1%	479	$3K
94770		<1%	21	$3K
82378		<1%	2,864	$3K
72131		<1%	69	$3K
77012		<1%	93	$3K
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	71	$3K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	272	$3K
81206		<1%	26	$3K
72070		<1%	127	$3K
0003A		<1%	116	$3K
86039		<1%	734	$3K
86200		<1%	1,368	$3K
L3933	Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment	<1%	71	$3K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,318	$3K
84480		<1%	503	$3K
94664		<1%	291	$3K
82947		<1%	10,288	$3K
72120		<1%	203	$3K
93290		<1%	444	$2K
0052A		<1%	68	$2K
74210		<1%	86	$2K
90744		<1%	318	$2K
82103		<1%	450	$2K
A4215	Needle, sterile, any size, each	<1%	4,481	$2K
73551		<1%	216	$2K
92082		<1%	38	$2K
86677		<1%	102	$2K
84295		<1%	9,733	$2K
80358		<1%	505	$2K
72128		<1%	41	$2K
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	118	$2K
0083A		<1%	41	$2K
86800		<1%	258	$2K
82610		<1%	473	$2K
92553		<1%	24	$2K
72083		<1%	58	$2K
96119		<1%	175	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,931	$2K
82435		<1%	9,442	$2K
86618		<1%	384	$2K
86147		<1%	149	$2K
0121A		<1%	116	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,939	$2K
87506		<1%	14	$2K
86593		<1%	848	$2K
76514		<1%	57	$2K
86036		<1%	356	$2K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	8,930	$2K
81404		<1%	21	$2K
82390		<1%	410	$2K
86141		<1%	525	$2K
86870		<1%	131	$2K
81401		<1%	15	$2K
80353		<1%	688	$2K
80365		<1%	560	$2K
88275		<1%	96	$2K
76001		<1%	232	$2K
83525		<1%	192	$2K
88364		<1%	159	$2K
85049		<1%	878	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,949	$2K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	505	$2K
90632		<1%	148	$2K
87075		<1%	2,537	$2K
86334		<1%	556	$1K
72072		<1%	135	$1K
86777		<1%	228	$1K
87015		<1%	1,560	$1K
85520		<1%	118	$1K
0172A		<1%	36	$1K
85347		<1%	2,548	$1K
85384		<1%	723	$1K
86885		<1%	2,528	$1K
74022		<1%	318	$1K
88311		<1%	584	$1K
0051A		<1%	74	$1K
75580		<1%	16	$1K
85597		<1%	237	$1K
51736		<1%	91	$1K
L3809	Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type	<1%	102	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,943	$1K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	13	$1K
84166		<1%	267	$1K
85240		<1%	197	$1K
J1940	Injection, furosemide, up to 20 mg	<1%	2,150	$1K
86008		<1%	230	$1K
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	15	$1K
82040		<1%	408	$1K
84300		<1%	1,396	$1K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,293	$1K
G0009	Administration of pneumococcal vaccine	<1%	1,679	$1K
87206		<1%	1,928	$1K
93247		<1%	18	$963.63
86357		<1%	160	$961.02
70355		<1%	14	$958.03
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,539	$941.93
81406		<1%	21	$933.45
85014		<1%	342	$927.56
0074A		<1%	38	$925.53
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	13	$914.86
82945		<1%	682	$909.93
85612		<1%	237	$903.16
0171A		<1%	50	$901.38
11720		<1%	63	$895.60
36600		<1%	56	$881.79
J0780	Injection, prochlorperazine, up to 10 mg	<1%	5,053	$876.77
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,561	$869.12
80195		<1%	134	$867.53
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	<1%	32	$865.83
87999		<1%	105	$859.05
84681		<1%	81	$842.81
72156		<1%	13	$823.52
A4565	Slings	<1%	31	$816.00
85245		<1%	99	$796.45
0012A		<1%	21	$790.29
11721		<1%	124	$787.75
86769		<1%	241	$768.04
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,408	$751.52
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	49	$749.71
87493		<1%	170	$746.33
0011A		<1%	21	$687.69
82652		<1%	140	$672.64
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	823	$658.28
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,104	$652.16
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	975	$636.13
C2617	Stent, non-coronary, temporary, without delivery system	<1%	982	$628.69
J3489	Injection, zoledronic acid, 1 mg	<1%	65	$608.16
93242		<1%	15	$586.79
89230		<1%	15	$586.07
0064A		<1%	13	$576.94
86355		<1%	174	$576.26
0053A		<1%	31	$567.11
84460		<1%	666	$553.65
0151A		<1%	41	$537.82
86146		<1%	149	$531.04
84450		<1%	592	$509.13
90691		<1%	55	$497.48
J9267	Injection, paclitaxel, 1 mg	<1%	634	$485.23
84157		<1%	783	$480.66
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	134	$473.86
J2060	Injection, lorazepam, 2 mg	<1%	3,355	$451.31
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	16	$441.65
87106		<1%	41	$441.19
84155		<1%	582	$432.50
83013		<1%	31	$430.37
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	5,200	$411.14
C9447	Injection, phenylephrine and ketorolac, 4 ml vial	<1%	17	$407.38
92132		<1%	19	$400.85
0073A		<1%	12	$394.61
86381		<1%	150	$381.55
81302		<1%	20	$379.91
83090		<1%	80	$362.22
93356		<1%	851	$348.41
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	13	$347.50
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,965	$344.97
C1760	Closure device, vascular (implantable/insertable)	<1%	30	$339.28
84478		<1%	297	$324.34
J3480	Injection, potassium chloride, per 2 meq	<1%	2,125	$322.88
86902		<1%	108	$322.07
88302		<1%	60	$321.48
J9370	Vincristine sulfate, 1 mg	<1%	725	$320.12
85246		<1%	47	$317.24
G0390	Trauma response team associated with hospital critical care service	<1%	38	$315.01
C2625	Stent, non-coronary, temporary, with delivery system	<1%	27	$314.41
84540		<1%	423	$302.01
88346		<1%	253	$289.96
82139		<1%	14	$279.70
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,400	$232.64
86709		<1%	116	$229.23
86880		<1%	81	$221.03
96137		<1%	44	$221.00
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,935	$216.75
88377		<1%	13	$215.46
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,965	$213.95
83935		<1%	164	$204.35
J3411	Injection, thiamine hcl, 100 mg	<1%	2,055	$204.14
81405		<1%	21	$189.95
81321		<1%	20	$189.95
87324		<1%	52	$182.88
81241		<1%	15	$182.83
V2632	Posterior chamber intraocular lens	<1%	557	$173.25
J0640	Injection, leucovorin calcium, per 50 mg	<1%	529	$154.70
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,289	$153.02
80165		<1%	35	$136.92
J8501	Aprepitant, oral, 5 mg	<1%	15	$134.01
82340		<1%	68	$132.80
J1630	Injection, haloperidol, up to 5 mg	<1%	1,697	$129.36
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	7,602	$121.34
87176		<1%	259	$117.20
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	710	$113.44
86705		<1%	64	$113.07
82088		<1%	18	$110.51
C9113	Injection, pantoprazole sodium, per vial	<1%	538	$106.73
83520		<1%	55	$96.64
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,165	$93.10
83930		<1%	91	$88.37
C9290	Injection, bupivacaine liposome, 1 mg	<1%	295	$87.94
72084		<1%	13	$87.59
86765		<1%	42	$83.94
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	485	$81.51
85300		<1%	31	$76.39
88331		<1%	41	$73.64
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	528	$72.80
82438		<1%	28	$68.60
84133		<1%	87	$66.42
84436		<1%	29	$62.30
Q4038	Cast supplies, short leg cast, adult (11 years +), fiberglass	<1%	88	$60.76
80354		<1%	17	$60.53
90473		<1%	203	$59.66
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	2,058	$57.86
17003		<1%	253	$57.04
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	404	$55.98
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	356	$46.07
96377		<1%	61	$44.17
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	489	$44.02
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	293	$38.27
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	268	$35.67
99156		<1%	73	$34.73
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	83	$32.92
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	310	$32.24
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	1,591	$30.27
J0461	Injection, atropine sulfate, 0.01 mg	<1%	248	$30.16
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	447	$27.30
J0280	Injection, aminophyllin, up to 250 mg	<1%	140	$25.90
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	99	$25.71
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	357	$22.04
82010		<1%	29	$19.60
94760		<1%	82	$19.30
J1790	Injection, droperidol, up to 5 mg	<1%	356	$14.98
87184		<1%	15	$12.90
83021		<1%	13	$11.24
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	70	$11.02
J2720	Injection, protamine sulfate, per 10 mg	<1%	142	$10.33
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	241	$8.22
Q4010	Cast supplies, short arm cast, adult (11 years +), fiberglass	<1%	161	$7.40
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,288	$6.62
J1836	Injection, metronidazole, 10 mg	<1%	283	$4.88
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	102	$2.20
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	309	$1.33
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	0%	20	$0.00
C1781	Mesh (implantable)	0%	208	$0.00
Q4012	Cast supplies, short arm cast, pediatric (0-10 years), fiberglass	0%	43	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	98	$0.00
81407		0%	17	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	56	$0.00
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	0%	100	$0.00
S8096	Portable peak flow meter	0%	29	$0.00
38900		0%	14	$0.00
J2002	Injection, lidocaine hcl in 5% dextrose, 1 mg	0%	14	$0.00
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	0%	15	$0.00
J1921	Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg	0%	103	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	35	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	43	$0.00
88108		0%	57	$0.00
Q4008	Cast supplies, long arm cast, pediatric (0-10 years), fiberglass	0%	37	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	62	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	43	$0.00
J0611	Injection, calcium gluconate (wg critical care), per 10 ml	0%	24	$0.00
C1750	Catheter, hemodialysis/peritoneal, long-term	0%	23	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	43	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	256	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	993	$0.00
J8499	Prescription drug, oral, non chemotherapeutic, nos	0%	51	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	162	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	13	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	35	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	167	$0.00
Q9962	High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml	0%	26	$0.00
A4550	Surgical trays	0%	51	$0.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	0%	14	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	73	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	161	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	43	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	15	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	15	$0.00
81408		0%	15	$0.00
C1788	Port, indwelling (implantable)	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHORTON, WENDY (CEO)